virus-like particles
| 1 min read
In the 1930s, HPV
wasn’t on the radar for most scientists.Four decades passed before anyone connected
HPV with cervical, penile, or anal cancer, and it took even longer before scientists
developed a prophylactic vaccine.
| 6 min read
Pioneering approaches transform vaccine technologies and shape the future of disease prevention.
Available on Demand
Researchers investigate new approaches to revolutionizing vaccines for cancer and infectious diseases.
Page 1 of 1 - 3 Total Items
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
SubscribeSponsored
Reliable fluid biomarkers strategies for clinical neuroscience research
Explore how validated fluid biomarker assays advance clinical research for neurological diseases.
Understanding drug impurities: types, sources, and analytical strategies
Unseen and often unexpected, drug impurities can slip in at every drug development stage, making their detection and control essential.
Discovering cutting-edge nitrosamine analysis in pharmaceuticals
New tools help researchers detect and manage harmful nitrosamine impurities in drugs such as monoclonal antibodies.
